Inhibiting Cholesterol-associated Protein Reduces High-risk Blockages In Arteries

Using the drug darapladib, researchers have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.

Read the whole article on Science Daily

More from Science Daily